Skip to main navigation Skip to search Skip to main content

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous LY2127399 in Patients with Systemic Lupus Erythematosus (SLE) Protocol H9B-MC-BCDS

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date08/31/11 → 02/28/16

Funding

  • Lilly USA LLC: $9,500.00